These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39397256)
1. Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk. Chen C; Eworuke E; Rai A; Hou L; Ko JS; Southworth MR; Hernández-Muñoz JJ; Zhang M Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70040. PubMed ID: 39397256 [TBL] [Abstract][Full Text] [Related]
2. Hydrochlorothiazide Use and Risk of Skin Cancer: A Population-Based Retrospective Cohort Study. Yang AS; Djebarri L; Lee CN; Granados D; Moneim MA; Shao SC; Lin SJ; Liao TC; Lin HW; Lai EC Pharmacoepidemiol Drug Saf; 2024 Nov; 33(11):e70027. PubMed ID: 39444110 [TBL] [Abstract][Full Text] [Related]
3. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide? Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119 [TBL] [Abstract][Full Text] [Related]
4. Risk of Nonmelanoma Skin Cancer in Association With Use of Hydrochlorothiazide-Containing Products in the United States. Eworuke E; Haug N; Bradley M; Cosgrove A; Zhang T; Dee EC; Adimadhyam S; Petrone A; Lee H; Woodworth T; Toh S JNCI Cancer Spectr; 2021 Apr; 5(2):. PubMed ID: 33733052 [TBL] [Abstract][Full Text] [Related]
5. Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data. Zappalà T; Pottegård A; Huber CA; Reinau D; Meier CR; Spoendlin J Pharmacoepidemiol Drug Saf; 2024 Sep; 33(9):e70005. PubMed ID: 39223977 [TBL] [Abstract][Full Text] [Related]
6. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data. Kim JC; Kim YC; Choi JW Clin Exp Dermatol; 2021 Jun; 46(4):680-686. PubMed ID: 33215728 [TBL] [Abstract][Full Text] [Related]
7. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea. Park E; Lee Y; Jue MS Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528 [TBL] [Abstract][Full Text] [Related]
8. Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancer. Danieli C; Moura CS; Pilote L; Bernatsky S; Abrahamowicz M Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1411-1420. PubMed ID: 37528702 [TBL] [Abstract][Full Text] [Related]
9. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study. Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105 [TBL] [Abstract][Full Text] [Related]
10. Does hydrochlorothiazide increase the incidence of skin, lip and oral cancer in a UK population? Carney K; Cousins M Evid Based Dent; 2022 Mar; 23(1):38-39. PubMed ID: 35338330 [TBL] [Abstract][Full Text] [Related]
11. Geographical Differences in Hydrochlorothiazide Associated Risk of Skin Cancer Balanced Against Disability Related to Hypertensive Heart Disease. Almskou Rasmussen A; Buus NH; Comerma Steffensen SG Am J Hypertens; 2024 Oct; 37(11):924-932. PubMed ID: 39115345 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide. Chrysant SG; Weber MA; Wang AC; Hinman DJ Am J Hypertens; 2004 Mar; 17(3):252-9. PubMed ID: 15001200 [TBL] [Abstract][Full Text] [Related]
13. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346 [TBL] [Abstract][Full Text] [Related]
14. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. Krum H; Skiba M; Gilbert RE Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications. Neutel JM; Klein C; Meinicke TW; Schumacher H Blood Press; 2002; 11(5):302-9. PubMed ID: 12458653 [TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide use, sun exposure, and risk of keratinocyte cancer. VanWormer JJ; Abokede EB; Berg RL BMC Public Health; 2022 Jul; 22(1):1282. PubMed ID: 35780087 [TBL] [Abstract][Full Text] [Related]
17. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. Raskin P; Guthrie R; Flack J; Reeves R; Saini R J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738 [TBL] [Abstract][Full Text] [Related]
18. Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide. Moore MJ; Gong Y; Hou W; Hall K; Schmidt SO; Curry RW; Beitelshees AL; Chapman A; Turner ST; Schwartz GL; Bailey K; Boerwinkle E; Gums JG; Cooper-DeHoff RM; Johnson JA Pharmacotherapy; 2014 Nov; 34(11):1132-40. PubMed ID: 25202885 [TBL] [Abstract][Full Text] [Related]
19. The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study. de Haan-Du J; Landman GWD; Groenier KH; Vissers PAJ; Louwman MWJ; Kleefstra N; de Bock GH Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2114-2121. PubMed ID: 34493493 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. Oparil S; Aurup P; Snavely D; Goldberg A Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]